|Petros Nihoyannopoulos MD, FRCP, FESC, FACC, FAHA
Senior Consultant Cardiologist at Hammersmith Hospital and Professor at Imperial College London and the National Heart and Lung Institute, UK
His main research interest is in the study of heart muscle disorders, valvular heart disease as well as acute and chronic coronary syndromes using state-of-the-art echocardiography.
Director of Non-Invasive Cardiology and Associate Medical Director at King’s College Hospital, London, UK
His clinical interests include all aspects of advance Echocardiography, especial those related to structural interventions and 3D imaging.
|Richard P Steeds
Consultant Cardiologist , Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
Richard P Steeds is a Consultant Cardiologist at University Hospital (Queen Elizabeth) in Birmingham, specialising in cardiovascular imaging and in the management of valvular heart disease. He is the current President of the British Society of Echocardiography and a Lead Cardiologist in echocardiography and CMR. He is an Honorary Reader at the Institute of Cardiovascular Sciences, University of Birmingham, and has published more than 200 peer-reviewed research articles. His current research interests are in the role of CMR in the management of asymptomatic severe mitral regurgitation and in the prediction of cardiovascular complications from chronic kidney disease. He has an active interest in the management of cardiovascular aspects of rare diseases, including Alstrom syndrome.
Professor of Clinical Cardiology and Consultant Cardiologist at Guy’s and St Thomas’ Hospital
He is Head of Noninvasive Cardiology. His specialist clinical and research interests are in cardiac imaging and heart valve disease.
|Jeroen J Bax
Director of non-invasive imaging at the Leiden University Medical Centre in The Netherlands
His clinical interest are the integrative use of all modern non-invasive imaging techniques in clinical cardiology with specific interests in imaging in heart failure, ischemic heart disease and valvular disease.
Professor of Medicine and Cardiologist Prince of Wales Hospital, The Chinese University of Hong Kong (CUHK), Director (Clinical Science) of the Institute of Vascular Medicine, and Director of the Heart Education And Research Training (HEART) Centre in CUHK
His clinical and research interests include echocardiography and cardiovascular imaging, device therapy, percutaneous coronary intervention, heart failure and structural heart disease intervention.
|Anthony N DeMaria
Professor of Medicine and Chief, Division of Cardiology at the University of California, San Diego and founder of the UCSD Sulpizio Family Cardiovascular Center
His field of specialization is cardiac imaging techniques, particularly echocardiography.
|Natesa G Pandian
Professor of Medicine of Tufts University, a senior staff cardiologist at Tufts University Medical Center, and the Director of the Valve Center and Co-Director of Cardiovascular Imaging
His research interests include valve disease, pericardial disease, ventricular function and echocardiography.
Director of Cardiac Imaging at the Hospital Vall d´Hebron and Chairman and Co-director of Valvular and Aortic Diseases Lineas of the Spanish Network on Cardiovascular Research (RECAVA)
Professor of Cardiology and Cardiac Imaging at the Institute of Medical Sciences, University of Uppsala
His main research interest is cardiac imaging with a focus on valvular heart disease and left ventricular function.
St George’s, University of London, London, UK (Association of Cardiothoracic Anaesthetists)
Director of the Echo Lab for the Barts Heart Centre and University College Hospitals London
His special interests include valvular heart disease and stress echocardiography for structural indications.
Mayo Clinic, Pheonix, Arizona, USA
His area of clinical interest is the non-inavsive hemodyanamic echocardiography laboratory with research interests in valvular heart disease, pericaial diseases, coronary artery anomalies and within cardio-oncology early detetction and treatment of cardiotoxicities due to chemotherapy.
|Bogdan A Popescu
Associate Professor of Cardiology at the University of Medicine and Pharmacy and Consultant Cardiologist at the Institute of Cardiovascular Diseases, Bucharest
His main research interest is in the study of valvular heart disease and cardiac dysfunction/heart failure using advanced echocardiography techniques.
|Thomas R Porter
Professor of Medicine and Theodore F Hubbard Chair of Cardiology
Specialties include cardiovascular research and cardiac imaging.
John Radcliffe Hospital, Oxford, UK
Professor of Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Cardiologist and Director of Echocardiography at the Royal Brompton Hospital, London and Northwick Park Hospital, Harrow
His interests are heart failure, coronary artery disease, acute coronary syndrome and valvular heart disease.
Professor of Paediatric and Fetal Cardiology at the Evelina London Children’s Hospital
He has a particular interest in 3D echocardiography of congenital heart disease and fetal cardiology.
Head of the Department of Anaesthesia at the University of Cape Town
His special interests include adult and paediatric, cardiothoracic anaesthesia and perioperative transoesophageal echocardiography.
|COLLABORATING SOCIETY EDITORS|
Jewish General Hospital, McGill University, Montréal, Québec, Canada (Canadian Society of Echocardiography)
Rush University Medical Center, Chicago, IL, USA (International Contrast Ultrasound Society)
|Abdulhalim J Kinsara, FRCP, FACC
King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia (Saudi Arabian Society of Echocardiograhy)
Pediatrics - Cardiology, Stanford University, Stanford, CA, USA (Society of Pediatric Echocardiography)
The Newcastle upon Tyne Hospitals, Newcastle, UK (Association of Cardiothoracic Anaesthetists and Critical Care)
|Marcelo Luiz Campos Vieira, MD, PhD, FESC
Professor of Cardiology, São Paulo University Medical School, São Paulo, Brazil (President of the Echocardiography Association of Inter-American Society of Cardiology (ECOSIAC))
|Costantina Aggeli, MD, PhD, FESC – First Department of Cardiology, Hippokrateion Hospital, University of Athens, Greece|
|Aris Anastasakis, MD, PhD – First Department of Cardiology, University of Athens, Greece|
|George Athanasopoulos, MD, PhD, FESC – Onassis Cardiac Surgery Centre, Greece|
|Harald Becher, MD, PhD – University of Alberta Hospital, Mazankowski Alberta Heart Institute, Canada|
|Stefanie Bruemmer–Smith, MD – Brighton and Sussex University Hospital Trust, UK|
|Thomas Buck, MD, FACC, FESC – Department of Cardiology, Klinikum Westfalen, Dortmund, Germany|
|Derek Chin, MBBS, FRCP, CCST – Glenfield Hospital, University Hospitals of Leicester NHS Trust and University of Leicester Medical School, UK|
|Paolo Colonna, MD, FESC – Policlinico of Bari, Italy|
|Bernard Cosyns, MD, PhD – CHIREC and UZ Brussel, Belgium|
|Victoria Delgado, MD, PhD – Leiden University Medical Center, Netherlands|
|Perry Elliott, MD – The Heart Hospital, University College London, UK|
|Maurice Enriquez–Sarano, MD – Mayo Clinic, Rochester, MN, USA|
|Kevin Fox, MD, FRCP, FESC – Imperial College Healthcare NHS Trust, London, UK|
|Nicola Gaibazzi, MD, PhD – Cardiology Department, Parma University Hospital, Italy|
|Julia Grapsa, PhD – Imperial College London, UK|
|Kim Greaves, BSc, MD, FACC, FRCP – University of Queensland and Sunshine Coast Hospital and Health Service, Australia|
|Andreas Hagendorff, MD – Universitätsklinikum Leipzig AöR, Germany|
|Ignatios Ikonomidis, MD, PhD, FESC – Second Cardiology Department, University of Athens, Attikon Hospital, Haidari, Greece|
|Adrian Ionescu, MD – Morriston Cardiac Centre, Swansea, UK|
|Jarosław D Kasprzak, MD, FESC, FACC – Medical University of Lodz, Biegański Regional Specialty Hospital, Poland|
|Patrizzio Lancellotti, MD, PhD, FESC, FACC – University Hospital of Liège, Belgium|
|Stamatios Lerakis, MD, PhD – Emory University Hospital and Emory Clinic, Emory University School of Medicine, Atlanta, GA, USA|
|Julien Magne, PhD – Limoges University Hospital, France|
|Michael Main, MD – Saint Luke's Mid America Heart Institute, MO, USA|
|Sharon Mulvagh, MD – Mayo Clinic, Rochester, MN, USA|
|Aleksandar Nešković, MD, PhD, FESC, FACC – Clinical Hospital Center Zemun, Faculty of Medicine, University of Belgrade, Serbia|
|Hans–Joachim Nesser – Elisabethinen Teaching Hospital, Linz, Austria|
|Ellen Ostenfeld, MD, PhD – Department of Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden|
|David Oxborough, PhD – Research Institute for Sports and Exercise Physiology, Liverpool John Moores University, UK|
|Alexandros Patrianakos, MD – Heraklion University Hospital, Crete, Greece|
|Fausto Pinto, MD – Lisbon University Medical School, Portugal|
|Juan Carlos Plana – Cleveland Clinic, OH, USA|
|Loukianos Rallidis, MD – University General Hospital Attikon, Athens, Greece|
|Simon Ray, MD – University Hospital of South Manchester, UK|
|Raphael Rosenhek, MD, FESC – Medical University of Vienna, Austria|
|Partho Sengupta, MD, DM, FACC, FASE – Mount Sinai Hospital, New York, NY, USA|
|Vishal Sharma, MD, MRCP – Royal Liverpool and Broadgreen University Hospitals, UK|
|Peter Søgaard, MD, DMSc – Department of Cardiology and Clinical Medicine, Cardiovascular Research Center, Aalborg University Hospital, Denmark|
|Nilesh Sutaria, MBChB, FRCP, MD – Imperial College Healthcare NHS Trust, London, UK|
|Dragoş Vinereanu, MD, PhD – Carol Davila University of Medicine and Pharmacy, Bucharest, Romania|
|Jens–Uwe Voigt, MD, PhD – University Hospital Gasthuisberg, Catholic University Leuven, Belgium|
|Richard Wheeler, MBChB, FRCP – University Hospital of Wales, Cardiff, UK|
|José Zamorano, MD, PhD – University Hospital Ramon y Cajal, Madrid, Spain|
|William Zoghbi, MD, FASE, FAHA, MACC – Weill Cornell Medical College, Houston, TX, USA|
Editors' declarations are listed in the journal's Disclosure Policy.